Creed II: Kid Rocky heads to Russia for a Cold War rematchby James Robins
Now, we have a rematch. Adonis Creed, son of Apollo (Michael B Jordan), squares up to Drago’s hulking offspring Viktor (Florian Munteanu). Rocky and Ivan, the two faded former champions, are in their respective corners. But this is no rinse-and-repeat, for Creed II is about more than superpower combat: it’s about fathers and sons.
Boxing movies are formulaic by definition. The trick is in outsmarting the formula, which Creed II does rather well. Steven Caple Jr’s film, in part penned by Stallone, builds from the impressive virtuosity of Ryan Coogler’s first Creed: bigger, brawnier, and deeper.
Although there’s nothing to match the startlingly choreographed three-minute single-take round from the first film, the fights sound brutal and punishing; thunderclaps, not punches. Of course, a fight is worthless unless there’s something to fight for. Even a tinge of emotional authenticity can go a long way.
Stallone, Jordan, and yes, even Lundgren, bring a pointed vulnerability to their roles – a rather daring thing to do in a series about undiluted heroism. Humiliation can be devastating, identity hard to grasp, fatherhood loaded with anxieties. As one character quips: “The belt ain’t enough. You need a narrative.”
IN CINEMAS NOW
What do you do if your culture treats mental illness like a curse? Bury it deep.Read more
A review of the Amazon Echo Show smart speaker.Read more
Grace Millane's death is a reminder of the work that needs to be done to reduce violence directed at women in this country, says the PM.Read more
The possibility of Kiwis voting on three contentious issues – euthanasia, cannabis and an MMP shakeup – is like crowdsourcing political decisions.Read more
As a review stalks bullies in the corridors of power, Bill Ralston writes that abuse thrives in the darkness.Read more
In a world where cities are humungous all-terrain vehicles, Peter Jackson’s protégé gets bogged down.Read more
re-stART, an Auckland art therapy programme, is thought to be the first in the world targeting stroke survivors.Read more